AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in lawsuits brought by ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Pharmaceutical company AstraZeneca has initiated a global withdrawal of ...
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results